{"id":"NCT01126580","sponsor":"Eli Lilly and Company","briefTitle":"A Study in Participants With Type 2 Diabetes Mellitus (AWARD-3)","officialTitle":"The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-05","primaryCompletion":"2011-11","completion":"2012-06","firstPosted":"2010-05-19","resultsPosted":"2015-01-16","lastUpdate":"2015-01-16"},"enrollment":807,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"Metformin","otherNames":[]},{"type":"DRUG","name":"LY2189265","otherNames":["Dulaglutide"]},{"type":"DRUG","name":"Placebo (oral)","otherNames":[]},{"type":"DRUG","name":"Placebo (subcutaneous)","otherNames":[]}],"arms":[{"label":"1.5 mg LY2189265","type":"EXPERIMENTAL"},{"label":"0.75 mg LY2189265","type":"EXPERIMENTAL"},{"label":"Metformin","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to determine if LY2189265 is safe and effective in reducing glycosylated hemoglobin (HbA1c) as compared to metformin in participants with Type 2 Diabetes.","primaryOutcome":{"measure":"Change From Baseline to 26-week Endpoint in Glycosylated Hemoglobin (HbA1c)","timeFrame":"Baseline, 26 weeks","effectByArm":[{"arm":"1.5 mg LY2189265","deltaMin":-0.78,"sd":0.06},{"arm":"0.75 mg LY2189265","deltaMin":-0.71,"sd":0.06},{"arm":"Metformin","deltaMin":-0.56,"sd":0.06}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG001 vs OG002","p":"<0.001"},{"comp":"OG000 vs OG002","p":"0.002"},{"comp":"OG001 vs OG002","p":"0.020"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":17},"locations":{"siteCount":91,"countries":["United States","Argentina","Brazil","Canada","Croatia","Czechia","Finland","France","Germany","India","Mexico","Poland","Puerto Rico","Romania","Slovakia","South Africa","South Korea","Spain","United Kingdom"]},"refs":{"pmids":["32501595","27161178","26691396","24842985"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":15,"n":269},"commonTop":["Nausea","Diarrhoea","Vomiting","Nasopharyngitis","Headache"]}}